I have way more energy and dont feel uncomfortable in my own skin anymore
Joseph Dayan Leads Study on Potential of Weight-Loss and Diabetes Drugs Like Ozempic to Treat Disease Affecting 5 Million Americans Red Bank, New Jersey, May 6, 2025 The Institute for Advanced Reconstruction (IFAR) in conjunction with ARSA Research, today announced a prospective study that aims to explore the potential of GLP-1 receptor agonists (GLP-1 RAs) in treating lymphedema, a chronic and progressive condition that affects millions worldwide
GLP-1 receptor agonists work through multiple mechanisms to improve glycemic control
Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects
The final pellet was re-suspended in DMEM containing penicillin, streptomycin, 10% FBS, 1 g/ml insulin (Sigma), and 20 ng/ml epidermal growth factor (EGF, Sigma)
Current Human Clinical Trials The transition from animal models to human studies is now well underway
